BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,402,000 | +2.1% | 42,259 | +7.0% | 0.21% | -1.4% |
| Q1 2021 | $3,331,000 | +14.6% | 39,498 | +9.0% | 0.21% | +0.5% |
| Q4 2020 | $2,907,000 | +1.8% | 36,227 | +2.0% | 0.21% | -7.4% |
| Q3 2020 | $2,857,000 | -7.1% | 35,526 | -0.5% | 0.23% | -9.8% |
| Q2 2020 | $3,075,000 | +13.4% | 35,710 | +6.9% | 0.26% | +2.4% |
| Q1 2020 | $2,712,000 | -1.7% | 33,400 | +1.3% | 0.25% | +12.2% |
| Q4 2019 | $2,758,000 | +2.4% | 32,984 | +7.1% | 0.22% | +4.2% |
| Q3 2019 | $2,694,000 | +9.9% | 30,799 | +2.9% | 0.21% | +5.4% |
| Q2 2019 | $2,451,000 | +6.9% | 29,923 | +6.1% | 0.20% | +1.5% |
| Q1 2019 | $2,292,000 | +29.9% | 28,193 | +5.1% | 0.20% | +15.7% |
| Q4 2018 | $1,765,000 | -5.9% | 26,822 | +10.3% | 0.17% | +7.5% |
| Q3 2018 | $1,875,000 | +6.2% | 24,317 | +1.7% | 0.16% | -2.4% |
| Q2 2018 | $1,766,000 | +20.1% | 23,911 | +5.8% | 0.16% | +20.6% |
| Q1 2018 | $1,470,000 | -7.1% | 22,596 | -7.7% | 0.14% | -5.6% |
| Q4 2017 | $1,582,000 | +9.5% | 24,470 | +6.3% | 0.14% | +7.5% |
| Q3 2017 | $1,445,000 | +14.6% | 23,020 | +10.5% | 0.13% | +11.7% |
| Q2 2017 | $1,261,000 | +21.8% | 20,830 | +4.3% | 0.12% | +20.0% |
| Q1 2017 | $1,035,000 | +19.4% | 19,965 | +2.1% | 0.10% | +19.0% |
| Q4 2016 | $867,000 | -1.8% | 19,555 | +5.4% | 0.08% | -5.6% |
| Q3 2016 | $883,000 | +20.1% | 18,545 | +14.2% | 0.09% | +17.1% |
| Q2 2016 | $735,000 | +59.4% | 16,245 | +44.9% | 0.08% | +55.1% |
| Q1 2016 | $461,000 | +88.2% | 11,213 | +74.7% | 0.05% | +88.5% |
| Q4 2015 | $245,000 | – | 6,420 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |